Skip to main content

Physician specialty

Dermatopathology

Find: Dermatopathology →

At a glance

Practicing in the U.S.
988
Per 100,000 residents
0.3
Women
43%
Median years since graduating
24

Training path

  1. College (bachelor’s degree) 4 years
  2. Medical school (MD or DO) 4 years
  3. Dermatology or pathology residency 4 years
  4. Dermatopathology fellowship 1 year

Training after medical school: 5 years. From the start of college: about 13 years.

Usual minimum program lengths from ACGME program requirements. Some doctors take extra research years or a second fellowship.

Who they are

  • MD (DOs make up the rest) 95%
  • Women 43%
  • Graduated 35 or more years ago 24%
  • Offer telehealth 3%
  • Accept Medicare’s approved amount 95%

Sex and credentials from NPPES. Graduation year, telehealth and Medicare assignment from Medicare Care Compare, which covers clinicians enrolled in Medicare.

Where they practice

Loading map…

What they do most for Medicare patients

  • Pathology examination of tissue using a microscope, intermediate complexity 2,530,560
  • Destruction of precancer skin growth, 2-14 growths 264,650
  • Special stained specimen slides to examine tissue, initial procedure 198,004
  • Special stained specimen slides to examine tissue, each additional procedure 184,266
  • Special stained specimen slides to identify organisms including interpretation and report 159,009
  • Established patient office or other outpatient visit, 20-29 minutes 90,026
  • Pathology examination of tissue using a microscope, moderately low complexity 74,757
  • Destruction of precancer skin growth, 1 growth 66,174
  • Biopsy of related skin growth, first growth 33,603
  • Established patient office or other outpatient visit, 30-39 minutes 33,315
  • Destruction of skin growth, 1-14 growths 25,949
  • Special stained specimen slides to examine tissue including interpretation and report 22,579

See all services →

Services billed to traditional Medicare in 2023 (Physician and Other Practitioners data); drugs given in the office are left out.

What they prescribe most

See all drugs →

Share of this specialty’s Medicare Part D prescriptions in 2024, including refills. Select a drug to see which of these clinicians prescribe it most, and where.

Hospitals where the most work

See all hospitals →

Clinicians who list the hospital in Medicare Care Compare. The number opens the list of who works there.

Schools they graduated from most

  • Baylor College of Medicine 10
  • Tulane University School of Medicine 10
  • Johns Hopkins University School of Medicine 9
  • Ohio State University College of Medicine 8
  • Perelman School of Med at The University of Pennsylvania 8
  • University of Southern California Keck School of Medicine 8
  • University of Tennessee, Hsc, College of Medicine 8
  • University of Texas Southwestern Medical School at Dallas 8
  • University of Alabama School of Medicine 7
  • University of Arkansas College of Medicine 7

See all schools →

From Medicare Care Compare (Medicare-enrolled clinicians only).

Industry payments

Drug and device makers reported $977,000 in general payments to 346 clinicians in Dermatopathology in 2025. See who received the most

Source: CMS Open Payments, program year 2025. A payment is not evidence of wrongdoing.

Research in this field

U.S. researchers published 16,540 articles and reviews in dermatology in 2024–2026.

Journals with the most U.S. papers

  • Journal of the American Academy of Dermatology Elsevier BV 2,536
  • Journal of Investigative Dermatology Elsevier BV 1,478
  • Food and Chemical Toxicology Elsevier BV 573
  • JAAD Case Reports Elsevier BV 557
  • Archives of Dermatological Research Springer Science+Business Media 494
  • Cureus Cureus, Inc. 460
  • Dermatologic Surgery Lippincott Williams & Wilkins 404
  • SKIN The Journal of Cutaneous Medicine 387
  • British Journal of Dermatology Oxford University Press 309
  • International Journal of Dermatology Wiley 278

Most-cited recent papers

  1. Guidelines of care for the management of acne vulgaris (opens in a new tab) Journal of the American Academy of Dermatology, 2024 · cited 627 times · free to read
  2. Atopic dermatitis (opens in a new tab) The Lancet, 2025 · cited 357 times
  3. Overview of skin cancer types and prevalence rates across continents (opens in a new tab) Cancer Pathogenesis and Therapy, 2024 · cited 278 times · free to read
  4. Hidradenitis suppurativa (opens in a new tab) The Lancet, 2025 · cited 259 times · free to read
  5. Efficacy and safety of bimekizumab in patients with moderate-to-severe hidradenitis suppurativa (BE HEARD I and BE HEARD II): two 48-week, randomised, double-blind, placebo-controlled, multicentre phase 3 trials (opens in a new tab) The Lancet, 2024 · cited 213 times · free to read
  6. Dupilumab in patients with chronic spontaneous urticaria (LIBERTY-CSU CUPID): Two randomized, double-blind, placebo-controlled, phase 3 trials (opens in a new tab) Journal of Allergy and Clinical Immunology, 2024 · cited 183 times · free to read
  7. Photo-neuro-immuno-endocrinology: How the ultraviolet radiation regulates the body, brain, and immune system (opens in a new tab) Proceedings of the National Academy of Sciences, 2024 · cited 180 times · free to read
  8. Nemolizumab with concomitant topical therapy in adolescents and adults with moderate-to-severe atopic dermatitis (ARCADIA 1 and ARCADIA 2): results from two replicate, double-blind, randomised controlled phase 3 trials (opens in a new tab) The Lancet, 2024 · cited 174 times

From OpenAlex, an open index of research papers. Papers with at least one author at a U.S. institution, classified by subject; the subject covers the whole field, so related specialties share these lists. Citation counts change daily.

Sources: CMS NPPES (counts, sex, credentials), Medicare Care Compare (schools, graduation years, hospitals, telehealth), CMS Medicare Physician & Other Practitioners (2023) and Part D Prescribers (2024), CMS Open Payments (2025), ACGME program requirements (training length), OpenAlex (research), U.S. Census Bureau ACS 2020–2024 (population).